RankAlpha logo
Back to Rankings

BCYC

Bicycle TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
BCYC vs peer average
40/100
BCYC vs. peer average (F vs. D)
Grade spread
C 2 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

FATE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $299.56M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerFATEFate Therapeutics
BCYC
Bicycle Therapeutics
FATE
Fate Therapeutics
Grade
F
F
Momentum
13
21
Value
57
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs FATE

BCYC / FATE
Grade Position
Below peers
BCYC vs. peer average (F vs. D)
40/100
Momentum
13
FATE
Value
57
BCYC
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BCYC
1
FATE
Fate Therapeutics Inc Common
F
20/100
Even
2
SLN
Silence Therapeutics PLC ADR
C
60/100
-2
3
AMRN
Amarin Corporation Plc ADR
C
60/100
-2
4
HUMA
Humacyte Inc Common
F
20/100
Even
5
TENX
Tenax Therapeutics Inc Common
F
20/100
Even
FATE is the first peer returned for this comparison set.